Literature DB >> 21578165

Aquabis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethylidenediphophonato-κO,O']zinc(II) dihydrate.

Eleonora Freire1, Daniel R Vega.   

Abstract

In the title complex, [Zn(C(5)H(9)NO(7)P(2))(2)(H(2)O)]·2H(2)O, the zinc atom is coordinated by two zoledronate anions [zoledronate = (2-(1-imidazole)-1-hydr-oxy-1,1'-ethyl-idenediphophonate)] and one water mol-ecule. The coordination number is 5. There is one half-mol-ecule in the asymmetric unit, the zinc atom being located on a twofold rotation axis passing through the metal centre and the coordinating water O atom. The anion exists as a zwitterion with an overall charge of -1; the protonated nitro-gen in the ring has a positive charge and the two phospho-nates groups each have a single negative charge. Inter-molecular O-H⋯O hydrogen bonds link the mol-ecules. An N-H⋯O inter-action is also present.

Entities:  

Year:  2009        PMID: 21578165      PMCID: PMC2971399          DOI: 10.1107/S160053680904286X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background to bis­phospho­nates, see: Fleisch et al. (1968 ▶); Green et al. (1994 ▶); Fleisch (2000 ▶); Ross et al. (2004 ▶); Smith (2005 ▶); Ralston et al. (1989 ▶); Reid et al. (2005 ▶); Rauch & Glorieux (2005 ▶); Chesnut et al. (2004 ▶). For structures of transition metal (Ni, Co and Cu) complexes with the zoledronate anion, see: Cao et al. (2007 ▶, 2008 ▶). For metal complexes of other bis­phospho­nates (Etidronate and Pamidronate), see: Fernández et al. (2002 ▶); Li et al. (2008 ▶); Chen et al. (2008 ▶); Uchtman (1972 ▶). For a hexa­coordinated zinc(II)–zoledronate complex, see: Freire & Vega (2009 ▶).

Experimental

Crystal data

[Zn(C5H9N2O7P2)2(H2O)]·2H2O M = 661.58 Monoclinic, a = 12.089 (2) Å b = 9.858 (2) Å c = 18.831 (4) Å β = 95.09 (3)° V = 2235.3 (8) Å3 Z = 4 Mo Kα radiation μ = 1.48 mm−1 T = 293 K 0.20 × 0.18 × 0.09 mm

Data collection

Rigaku AFC6 diffractometer Absorption correction: ψ scan (North et al., 1968 ▶) T min = 0.75, T max = 0.87 2847 measured reflections 2208 independent reflections 1528 reflections with I > 2σ(I) R int = 0.054 3 standard reflections every 150 reflections intensity decay: <3%

Refinement

R[F 2 > 2σ(F 2)] = 0.032 wR(F 2) = 0.096 S = 1.00 2208 reflections 167 parameters H-atom parameters constrained Δρmax = 0.35 e Å−3 Δρmin = −0.87 e Å−3 Data collection: MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988 ▶); cell refinement: MSC/AFC Diffractometer Control Software; data reduction: MSC/AFC Diffractometer Control Software; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S160053680904286X/bq2166sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S160053680904286X/bq2166Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
[Zn(C5H9N2O7P2)2(H2O)]·2H2OF(000) = 1352
Mr = 661.58Dx = 1.966 Mg m3
Monoclinic, C2/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -C 2ycCell parameters from 42 reflections
a = 12.089 (2) Åθ = 8–25°
b = 9.858 (2) ŵ = 1.48 mm1
c = 18.831 (4) ÅT = 293 K
β = 95.09 (3)°Prism, colorless
V = 2235.3 (8) Å30.20 × 0.18 × 0.09 mm
Z = 4
Rigaku AFC6 diffractometer1528 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.054
graphiteθmax = 26.0°, θmin = 2.2°
ω/2θ scansh = −1→14
Absorption correction: ψ scan (North et al., 1968)k = −1→12
Tmin = 0.75, Tmax = 0.87l = −23→23
2847 measured reflections3 standard reflections every 150 reflections
2208 independent reflections intensity decay: <3%
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.032Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.096H-atom parameters constrained
S = 1.00w = 1/[σ2(Fo2) + (0.0521P)2 + 1.3378P] where P = (Fo2 + 2Fc2)/3
2208 reflections(Δ/σ)max = 0.001
167 parametersΔρmax = 0.35 e Å3
0 restraintsΔρmin = −0.87 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Zn10.50000.50532 (5)0.75000.02015 (15)
P10.64482 (6)0.41327 (8)0.61862 (4)0.01916 (19)
P20.76934 (6)0.48891 (8)0.75923 (4)0.01749 (19)
O10.71512 (19)0.6590 (2)0.64590 (11)0.0237 (5)
H10.71540.70930.68060.043 (12)*
O110.54208 (18)0.4259 (3)0.65807 (12)0.0299 (5)
O120.6205 (2)0.4826 (2)0.54319 (13)0.0288 (5)
H120.62710.43690.50750.050 (14)*
O130.68721 (19)0.2707 (2)0.61059 (12)0.0277 (5)
O210.66152 (17)0.5108 (2)0.79201 (11)0.0253 (5)
O220.85809 (18)0.5945 (2)0.79009 (12)0.0269 (5)
H220.83390.64910.81770.051 (14)*
O230.81904 (19)0.3498 (2)0.76479 (12)0.0280 (5)
O1W0.50000.7080 (4)0.75000.0727 (17)
H1W0.55650.75300.74700.109*
O2W0.6191 (2)0.3463 (3)0.42704 (13)0.0394 (6)
H2WA0.58990.39100.39370.059*
H2WB0.67900.31240.41960.059*
N10.8788 (2)0.5706 (3)0.56618 (13)0.0218 (5)
N20.8895 (2)0.7275 (3)0.48801 (15)0.0328 (7)
H20.89720.80600.46910.039*
C10.7536 (2)0.5248 (3)0.66243 (16)0.0183 (6)
C20.8707 (2)0.5064 (3)0.63530 (16)0.0216 (6)
H2A0.92620.54530.66980.026*
H2B0.88650.41030.63150.026*
C30.8930 (3)0.7035 (3)0.55705 (18)0.0278 (7)
H30.90340.76800.59310.033*
C40.8718 (3)0.6092 (4)0.45095 (19)0.0351 (8)
H40.86570.59910.40170.042*
C50.8649 (3)0.5096 (4)0.49990 (17)0.0282 (7)
H50.85300.41780.49070.034*
U11U22U33U12U13U23
Zn10.0189 (2)0.0212 (3)0.0206 (3)0.0000.00281 (18)0.000
P10.0201 (4)0.0188 (4)0.0187 (4)−0.0007 (3)0.0023 (3)−0.0026 (3)
P20.0181 (4)0.0171 (4)0.0172 (4)0.0010 (3)0.0010 (3)0.0012 (3)
O10.0348 (12)0.0148 (10)0.0211 (11)0.0063 (9)−0.0003 (9)0.0005 (9)
O110.0207 (11)0.0397 (14)0.0304 (13)−0.0072 (10)0.0080 (9)−0.0142 (11)
O120.0363 (13)0.0275 (12)0.0217 (11)0.0036 (10)−0.0033 (10)−0.0023 (10)
O130.0378 (13)0.0175 (11)0.0282 (11)0.0015 (10)0.0044 (10)−0.0035 (10)
O210.0190 (10)0.0362 (13)0.0208 (11)0.0021 (9)0.0029 (8)−0.0011 (10)
O220.0231 (11)0.0291 (13)0.0284 (12)−0.0052 (9)0.0019 (9)−0.0081 (11)
O230.0360 (13)0.0193 (11)0.0296 (12)0.0064 (9)0.0072 (10)0.0062 (9)
O1W0.025 (2)0.0195 (19)0.177 (6)0.0000.027 (3)0.000
O2W0.0535 (17)0.0414 (15)0.0233 (12)0.0094 (13)0.0041 (11)−0.0019 (11)
N10.0212 (12)0.0244 (13)0.0203 (13)−0.0008 (10)0.0051 (10)−0.0006 (12)
N20.0363 (16)0.0302 (15)0.0324 (15)−0.0009 (12)0.0062 (13)0.0132 (14)
C10.0207 (14)0.0144 (13)0.0197 (14)0.0035 (11)0.0020 (11)0.0013 (11)
C20.0193 (14)0.0239 (16)0.0217 (15)−0.0002 (12)0.0025 (12)0.0034 (13)
C30.0288 (17)0.0252 (16)0.0304 (18)−0.0040 (13)0.0073 (13)0.0004 (14)
C40.0333 (19)0.049 (2)0.0230 (17)0.0047 (16)0.0012 (14)0.0041 (17)
C50.0291 (17)0.0322 (18)0.0237 (16)−0.0001 (14)0.0044 (13)−0.0070 (15)
Zn1—O1W1.999 (4)O1W—H1W0.8200
Zn1—O112.006 (2)O2W—H2WA0.8200
Zn1—O11i2.006 (2)O2W—H2WB0.8200
Zn1—O21i2.041 (2)N1—C31.335 (4)
Zn1—O212.041 (2)N1—C51.382 (4)
P1—O131.508 (2)N1—C21.458 (4)
P1—O111.508 (2)N2—C31.318 (4)
P1—O121.580 (2)N2—C41.366 (5)
P1—C11.851 (3)N2—H20.8600
P2—O231.497 (2)C1—C21.558 (4)
P2—O211.506 (2)C2—H2A0.9700
P2—O221.569 (2)C2—H2B0.9700
P2—C11.850 (3)C3—H30.9300
O1—C11.427 (3)C4—C51.355 (5)
O1—H10.8200C4—H40.9300
O12—H120.8200C5—H50.9300
O22—H220.8200
O1W—Zn1—O11112.97 (8)H2WA—O2W—H2WB114.6
O1W—Zn1—O11i112.97 (7)C3—N1—C5108.5 (3)
O11—Zn1—O11i134.06 (15)C3—N1—C2124.1 (3)
O1W—Zn1—O21i88.48 (7)C5—N1—C2127.2 (3)
O11—Zn1—O21i89.03 (9)C3—N2—C4109.9 (3)
O11i—Zn1—O21i92.16 (9)C3—N2—H2125.0
O1W—Zn1—O2188.48 (7)C4—N2—H2125.0
O11—Zn1—O2192.16 (9)O1—C1—C2108.9 (2)
O11i—Zn1—O2189.03 (9)O1—C1—P2113.3 (2)
O21i—Zn1—O21176.96 (14)C2—C1—P2106.45 (19)
O13—P1—O11115.37 (14)O1—C1—P1104.41 (18)
O13—P1—O12110.54 (13)C2—C1—P1114.5 (2)
O11—P1—O12108.12 (14)P2—C1—P1109.42 (15)
O13—P1—C1111.36 (13)N1—C2—C1112.1 (2)
O11—P1—C1108.35 (13)N1—C2—H2A109.2
O12—P1—C1102.23 (13)C1—C2—H2A109.2
O23—P2—O21117.33 (14)N1—C2—H2B109.2
O23—P2—O22108.95 (14)C1—C2—H2B109.2
O21—P2—O22109.95 (13)H2A—C2—H2B107.9
O23—P2—C1104.47 (13)N2—C3—N1108.1 (3)
O21—P2—C1111.03 (13)N2—C3—H3126.0
O22—P2—C1104.20 (13)N1—C3—H3126.0
C1—O1—H1114.1C5—C4—N2106.7 (3)
P1—O11—Zn1137.76 (14)C5—C4—H4126.6
P1—O12—H12118.4N2—C4—H4126.6
P2—O21—Zn1132.07 (13)C4—C5—N1106.8 (3)
P2—O22—H22113.5C4—C5—H5126.6
Zn1—O1W—H1W122.7N1—C5—H5126.6
O13—P1—O11—Zn1114.0 (2)O13—P1—C1—O1162.06 (18)
O12—P1—O11—Zn1−121.6 (2)O11—P1—C1—O1−70.0 (2)
C1—P1—O11—Zn1−11.6 (3)O12—P1—C1—O144.0 (2)
O1W—Zn1—O11—P170.5 (2)O13—P1—C1—C243.0 (2)
O11i—Zn1—O11—P1−109.5 (2)O11—P1—C1—C2170.9 (2)
O21i—Zn1—O11—P1158.5 (2)O12—P1—C1—C2−75.0 (2)
O21—Zn1—O11—P1−18.7 (2)O13—P1—C1—P2−76.38 (17)
O23—P2—O21—Zn1−95.2 (2)O11—P1—C1—P251.53 (18)
O22—P2—O21—Zn1139.62 (18)O12—P1—C1—P2165.57 (14)
C1—P2—O21—Zn124.8 (2)C3—N1—C2—C178.5 (4)
O1W—Zn1—O21—P2−102.54 (19)C5—N1—C2—C1−96.1 (3)
O11—Zn1—O21—P210.4 (2)O1—C1—C2—N1−39.8 (3)
O11i—Zn1—O21—P2144.5 (2)P2—C1—C2—N1−162.3 (2)
O23—P2—C1—O1−175.2 (2)P1—C1—C2—N176.6 (3)
O21—P2—C1—O157.4 (2)C4—N2—C3—N10.6 (4)
O22—P2—C1—O1−60.9 (2)C5—N1—C3—N2−0.6 (4)
O23—P2—C1—C2−55.5 (2)C2—N1—C3—N2−176.1 (3)
O21—P2—C1—C2177.09 (19)C3—N2—C4—C5−0.3 (4)
O22—P2—C1—C258.8 (2)N2—C4—C5—N10.0 (4)
O23—P2—C1—P168.72 (17)C3—N1—C5—C40.4 (4)
O21—P2—C1—P1−58.67 (18)C2—N1—C5—C4175.7 (3)
O22—P2—C1—P1−176.99 (13)
D—H···AD—HH···AD···AD—H···A
O12—H12···O2W0.821.752.566 (3)171
O22—H22···O13ii0.821.842.645 (3)167
O2W—H2WA···O21iii0.822.382.990 (3)132
O2W—H2WB···O13iv0.821.942.758 (4)173
N2—H2···O12v0.862.112.917 (4)157
O1W—H1W···O23ii0.821.812.632 (3)177
O1—H1···O23ii0.821.802.581 (3)160
Zn1—O1W1.999 (4)
Zn1—O112.006 (2)
Zn1—O212.041 (2)
O1W—Zn1—O11112.97 (8)
O11—Zn1—O11i134.06 (15)
O11—Zn1—O21i89.03 (9)
O1W—Zn1—O2188.48 (7)
O11—Zn1—O2192.16 (9)
O21i—Zn1—O21176.96 (14)

Symmetry code: (i) .

Table 2

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O12—H12⋯O2W0.821.752.566 (3)171
O22—H22⋯O13ii0.821.842.645 (3)167
O2W—H2WA⋯O21iii0.822.382.990 (3)132
O2W—H2WB⋯O13iv0.821.942.758 (4)173
N2—H2⋯O12v0.862.112.917 (4)157
O1W—H1W⋯O23ii0.821.812.632 (3)177
O1—H1⋯O23ii0.821.802.581 (3)160

Symmetry codes: (ii) ; (iii) ; (iv) ; (v) .

  14 in total

1.  Copper diphosphonates with zero-, one- and two-dimensional structures: ferrimagnetism in layer compound Cu3(ImhedpH)(2).2H2O [ImhedpH4=(1-C3H3N2)CH2C(OH)(PO3H2)2].

Authors:  Deng-Ke Cao; Xiao-Ji Xie; Yi-Zhi Li; Li-Min Zheng
Journal:  Dalton Trans       Date:  2008-08-07       Impact factor: 4.390

2.  Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Authors:  S H Ralston; S J Gallacher; U Patel; F J Dryburgh; W D Fraser; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

3.  Osteogenesis imperfecta, current and future medical treatment.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Am J Med Genet C Semin Med Genet       Date:  2005-11-15       Impact factor: 3.908

Review 4.  Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.

Authors:  Matthew R Smith
Journal:  Cancer Treat Rev       Date:  2005-10-14       Impact factor: 12.111

5.  Diaqua-bis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethyl-idenediphophonato-κO,O']zinc(II).

Authors:  Eleonora Freire; Daniel R Vega
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23

6.  Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.

Authors:  J R Green; K Müller; K A Jaeggi
Journal:  J Bone Miner Res       Date:  1994-05       Impact factor: 6.741

7.  Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Authors:  Charles H Chesnut; Arne Skag; Claus Christiansen; Robert Recker; Jacob A Stakkestad; Arne Hoiseth; Dieter Felsenberg; Hermann Huss; Jennifer Gilbride; Ralph C Schimmer; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

8.  The calcium-binding properties of pamidronate, a bone-resorption inhibitor.

Authors:  Daniel Fernández; Daniel Vega; Andrés Goeta
Journal:  Acta Crystallogr C       Date:  2002-09-21       Impact factor: 1.172

9.  Layered cobalt(II) and nickel(II) diphosphonates showing canted antiferromagnetism and slow relaxation behavior.

Authors:  Deng-Ke Cao; Yi-Zhi Li; Li-Min Zheng
Journal:  Inorg Chem       Date:  2007-08-09       Impact factor: 5.165

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more
  3 in total

1.  Diaqua-bis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethyl-idenediphophonato-κO,O']zinc(II).

Authors:  Eleonora Freire; Daniel R Vega
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23

2.  High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases.

Authors:  Gabriel Quiñones Vélez; Lesly Carmona-Sarabia; Alondra A Rivera Raíces; Tony Hu; Esther A Peterson-Peguero; Vilmalí López-Mejías
Journal:  Mater Adv       Date:  2022-02-23

3.  Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.

Authors:  Maria Vassaki; Savvina Lazarou; Petri Turhanen; Duane Choquesillo-Lazarte; Konstantinos D Demadis
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.